Approve this article for publication
J Card Surg. 2021 Jul;36(7):2596-2597. doi: 10.1111/jocs.15520. Epub 2021 Mar 30.
ABSTRACT
Throughout the world, a shortage of donor organs has prompted development of unique strategies to expand the donor pool. Here, we review a report by Medressova and
Approve this article for publication
Transplant Direct. 2021 May 18;7(6):e699. doi: 10.1097/TXD.0000000000001148. eCollection 2021 Jun.
ABSTRACT
Hearts from older donors or procured via donation after circulatory death (DCD) can alleviate transplant waitlist; however, these hearts are particularly vulnerable to injury caused by warm ischemic
Approve this article for publication
Interact Cardiovasc Thorac Surg. 2021 May 10;32(5):683-694. doi: 10.1093/icvts/ivaa333.
ABSTRACT
OBJECTIVES: The use of ‘extended criteria’ donor hearts and reconditioned hearts from donation after circulatory death has corresponded with an increase in primary graft dysfunction, with ischaemia-reperfusion injury being
Approve this article for publication
Ann Palliat Med. 2021 Jun;10(6):7151-7152. doi: 10.21037/apm-2021-04. Epub 2021 May 18.
NO ABSTRACT
PMID:34044574 | DOI:10.21037/apm-2021-04
Approve this article for publication
Transplant Direct. 2021 Feb 22;7(3):e676. doi: 10.1097/TXD.0000000000001120. eCollection 2021 Mar.
ABSTRACT
Organ donation after euthanasia is performed in an increasing number of countries. In this donation after circulatory death procedure, it has not been possible to donate the heart.
Approve this article for publication
Ann Thorac Surg. 2021 Jun 4:S0003-4975(21)00982-6. doi: 10.1016/j.athoracsur.2021.05.025. Online ahead of print.
ABSTRACT
BACKGROUND: Mortality for infants on the heart transplant wait list remains unacceptably high, and available mechanical circulatory support is suboptimal. Our goal is to demonstrate the
Approve this article for publication
JAMA Cardiol. 2021 Jun 23:e211825. doi: 10.1001/jamacardio.2021.1825. Online ahead of print.
ABSTRACT
IMPORTANCE: Coronary artery disease (CAD) and coronary microvascular dysfunction (CMD) may contribute to the pathophysiologic characteristics of heart failure with preserved ejection fraction (HFpEF). However, the prevalence
Approve this article for publication
J Card Surg. 2021 Sep;36(9):3421-3424. doi: 10.1111/jocs.15733. Epub 2021 Jun 12.
ABSTRACT
BACKGROUND: Heart transplantation from controlled donation after the circulatory determination of death (cDCDD) may be an option to increase the pool of grafts for transplantation.
MATERIALS AND METHODS:
Approve this article for publication
Front Immunol. 2021 Jun 9;12:667093. doi: 10.3389/fimmu.2021.667093. eCollection 2021.
ABSTRACT
BACKGROUND: Perioperative cardiac xenograft dysfunction (PCXD) describes a rapidly developing loss of cardiac function after xenotransplantation. PCXD occurs despite genetic modifications to increase compatibility of the heart. We report
Approve this article for publication
World J Transplant. 2021 Jun 18;11(6):203-211. doi: 10.5500/wjt.v11.i6.203.
ABSTRACT
Hyperkalemia is a recognized and potentially life-threatening complication of heart transplantation. In the complex biosystem created by transplantation, recipients are susceptible to multiple mechanisms for hyperkalemia which are discussed in
